Cargando…

Bevacizumab or laser for aggressive posterior retinopathy of prematurity

PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302568/ https://www.ncbi.nlm.nih.gov/pubmed/30637196 http://dx.doi.org/10.4103/tjo.tjo_69_18

Ejemplares similares

Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019)

Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019)

Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity
por: Fukushima, Yoko, et al.
Publicado: (2018)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
por: Naravane, Ameay V., et al.
Publicado: (2022)

Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis
por: Nicoară, Simona D., et al.
Publicado: (2016)

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
por: Kim, Rebecca, et al.
Publicado: (2014)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012)

Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment
por: Narnaware, Shilpi H, et al.
Publicado: (2021)

Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022)

Macular Development in Aggressive Posterior Retinopathy of Prematurity
por: Pandya, Hemang K., et al.
Publicado: (2015)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016)

Aggressive Posterior Retinopathy of Prematurity in a Premature Male Infant
por: Zhou, Jun, et al.
Publicado: (2017)

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
por: Nicoară, Simona Delia, et al.
Publicado: (2015)

Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity
por: Gangwe, Anil Babanrao, et al.
Publicado: (2021)

Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity
por: Jeon, Seung Hee, et al.
Publicado: (2021)

Longitudinal Development of Refractive Error in Children Treated With Intravitreal Bevacizumab or Laser for Retinopathy of Prematurity
por: Simmons, Michael, et al.
Publicado: (2021)

Comprehensive Retinal Image Analysis for Aggressive Posterior Retinopathy of Prematurity
por: Rajashekar, Deepthi, et al.
Publicado: (2016)

Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity
por: Chandra, Parijat, et al.
Publicado: (2019)

Up close with the vascular loops in aggressive posterior retinopathy of prematurity
por: Raju, Biju, et al.
Publicado: (2019)

Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity
por: Abdel Salam Gomaa, Nancy, et al.
Publicado: (2021)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Successful treatment of aggressive posterior retinopathy of prematurity with diode laser in ocular albinism: A case report
por: Gangwe, Anil B, et al.
Publicado: (2019)

Aggressive posterior retinopathy of prematurity in infants ≥1500 g birth weight
por: Sanghi, Gaurav, et al.
Publicado: (2014)

Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity
por: Shah, Parag K., et al.
Publicado: (2014)

The restless retina in aggressive posterior retinopathy of prematurity: prevention is better than cure
por: Chandra, Parijat, et al.
Publicado: (2018)

The restless retina in aggressive posterior retinopathy of prematurity: prevention is better than cure
por: Chandra, Parijat, et al.
Publicado: (2017)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
por: Kara, Caner, et al.
Publicado: (2017)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
por: Vinekar, Anand
Publicado: (2021)

Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity
por: Roohipoor, Ramak, et al.
Publicado: (2018)

Role of deferred retinal laser following intravitreal injection of bevacizumab in treatment of severe retinopathy of prematurity
por: Bhat, Vishalakshi, et al.
Publicado: (2023)

Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment
por: Lien, Reyin, et al.
Publicado: (2016)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity
por: Jang, Ji Hye, et al.
Publicado: (2023)

Posterior laser barrage in advancing retinopathy of prematurity: A prospective randomized study
por: Tewari, Ruchir, et al.
Publicado: (2019)

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
por: Xu, Yu, et al.
Publicado: (2016)

Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab
por: Tong, Qizhe, et al.
Publicado: (2018)

Comparison of Clinical Outcomes of Intravitreal Bevacizumab and Aflibercept in Type 1 Prethreshold Retinopathy of Prematurity in Posterior Zone II
por: Eftekhari Milani, Amir, et al.
Publicado: (2022)

Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysis
por: Xie, Edward F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tfqsqbb7e4o7nhhdc58uimnrkk